Anthony P. Mack - 25 Jan 2023 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
25 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Feb 2023, 20:30:11 UTC
Date Of Original Report
27 Jan 2023
Previous filing
20 May 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +125,000 $0.000000 125,000 25 Jan 2023 Common Stock 125,000 $0.8670 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments commencing on January 25, 2024.

Remarks:

This amendment on Form 4/A is being filed to amend the Form 4 filed on January 27, 2023, solely to correct inadvertent errors in the exercise price and expiration date of the Stock Option previously reported in Column 2 and Column 6 of Table II, respectively.